The Impact of Multiple Metastatic Nodal Stations on Survival in Patients With Resectable N1 and N2 Nonsmall-Cell Lung Cancer

Annals of Thoracic Surgery

Volumn 86, Issue 4, 2008, Pages 1092-1097

  Kang, Chang Hyun ^a   Ra, Yong Joon ^a   Kim, Young Tae ^a   Jheon, Sang Hoon ^b   Sung, Sook whan ^b   Kim, Joo Hyun ^a  

^a Seoul National University Hospital   (South Korea)

^b Seoul National University Bundang Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SURGERY; CANCER SURVIVAL; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; LUNG LOBECTOMY; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SURGICAL MORTALITY;

AGED; ANALYSIS OF VARIANCE; BIOPSY, NEEDLE; CARCINOMA, NON-SMALL-CELL LUNG; CAUSE OF DEATH; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PNEUMONECTOMY; PROBABILITY; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 52049114158     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2008.06.056     Document Type: Article

References (25)

1. Mountain C.F. Revisions in the international system for staging lung cancer. Chest 111 (1997) 1710-1717
2. Friedel G., Steger V., Kyriss T., Zoller J., and Toomes H. Prognosis in N2 NSCLC. Lung Cancer 45 Suppl (2004) 45-53
3. Goya T., Asamura H., Yoshimura H., et al. Prognosis of 6644 resected non-small cell lung cancers in Japan: a Japanese lung cancer registry study. Lung Cancer 50 (2005) 227-234
4. Robinson L.A., Ruckdeschel J.C., Wagner Jr. H., and Stevens C.W. Treatment of non-small cell lung cancer-stage IIIA: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 132 Suppl (2007) 243-265
5. van Meerbeeck J.P., Kramer G.W., Van Schil P.E., et al. Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer. J Natl Cancer Inst 99 (2007) 442-450
6. Garrido P., Gonzalez-Larriba J.L., Insa A., et al. Long-term survival associated with complete resection after induction chemotherapy in stage IIIA (N2) and IIIB (T4N0-1) non small-cell lung cancer patients: the Spanish Lung Cancer Group Trial 9901. J Clin Oncol 25 (2007) 4736-4742
7. Yokomise H., Gotoh M., Okamoto T., et al. Induction chemoradiotherapy (carboplatin-taxane and concurrent 50-Gy radiation) for bulky cN2, N3 non-small cell lung cancer. J Thorac Cardiovas Surg 133 (2007) 1179-1185
8. Scott W.J., Howington J., Feigenberg S., Movsas B., and Pisters K. Treatment of non-small cell lung cancer stage I and stage II: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 132 Suppl (2007) 234-242
9. Okada M., Sakamoto T., Yuki T., et al. Border between N1 and N2 stations in lung carcinoma: lessons from lymph node metastatic patterns of lower lobe tumors. J Thorac Cardiovasc Surg 129 (2005) 825-830
10. Riquet M., Manac'h D., Le Pimpec-Barthes F., Dujon A., and Chehab A. Prognostic significance of surgical-pathologic N1 disease in nonsmall-cell carcinoma of the lung. Ann Thorac Surg 67 (1999) 1572-1576
11. Asamura H., Suzuki K., Kondo H., and Tsuchiya R. Where is the boundary between N1 and N2 stations in lung cancer?. Ann Thorac Surg 70 (2000) 1839-1845
12. Fujimoto T., Cassivi S.D., Yang P., et al. Completely resected N1 non-small cell lung cancer: factors affecting recurrence and long-term survival. J Thorac Cardiovasc Surg 132 (2006) 499-506
13. Osaki T., Nagashima A., Yoshimatsu T., Tashima Y., and Yasumoto K. Survival and characteristics of lymph node involvement in patients with N1 non-small cell lung cancer. Lung Cancer 43 (2004) 151-157
14. Sawyer T.E., Bonner J.A., Gould P.M., et al. Factors predicting patterns of recurrence after resection of N1 nonsmall-cell lung carcinoma. Ann Thorac Surg 68 (1999) 1171-1176
15. Ichinose Y., Kato H., Koike T., et al. Completely resected stage IIIA non-small cell lung cancer: the significance of primary tumor location and N2 station. J Thorac Cardiovasc Surg 122 (2001) 803-808
16. Sawabata N., Keller S.M., Matsumura A., et al. The impact of residual multi-level N2 disease after induction therapy for non-small cell lung cancer. Lung Cancer 42 (2003) 69-77
17. Watanabe Y., Shimizu J., Oda M., et al. Aggressive surgical intervention in N2 nonsmall-cell cancer of the lung. Ann Thorac Surg 51 (1991) 253-261
18. Luzzi L., Paladini P., Ghiribelli C., et al. Assessing the prognostic value of the extent of mediastinal lymph node infiltration in surgically-treated non-small cell lung cancer (NSCLC). Lung Cancer 30 (2000) 99-105
19. Rusch V.W., Crowley J., Giroux D.J., et al. The IASLC lung cancer staging project: proposals for the revision of the N descriptors in the forthcoming seventh edition of the TNM classification for lung cancer. J Thorac Oncol 2 (2007) 603-612
20. Ruckdeschel J.C. Combined modality therapy of non-small cell lung cancer. Semin Oncol 24 (1997) 429-439
21. Andre F., Grunenwald D., Pignon J.P., et al. Survival of patients with resected N2 non-small-cell lung cancer: evidence for a subclassification and implications. J Clin Oncol 18 (2000) 2981-2989
22. Martini N., Flehinger B.J., Zaman M.B., and Beattie Jr. E.J. Prospective study of 445 lung carcinomas with mediastinal lymph node metastases. J Thorac Cardiovasc Surg 80 (1980) 390-399
23. Naruke T., Goya T., Tsuchiya R., and Suemasu K. The importance of surgery to nonsmall-cell carcinoma of lung with mediastinal lymph node metastasis. Ann Thorac Surg 46 (1988) 603-610
24. Lee P.C., Port J.L., Korst R.J., et al. Risk factors for occult mediastinal metastases in clinical stage I nonsmall-cell lung cancer. Ann Thorac Surg 84 (2007) 177-181
25. Choi I.S., Oh D.Y., Kwon J.H., et al. Paclitaxel/platinum-based perioperative chemotherapy and surgery in stage IIIA non-small cell lung cancer. Jpn J Clin Oncol 35 (2005) 6-12